Schoser, B, Attarian, S, Graham, R, Holdbrook, F, Goldman, M, Díaz-Manera, J. Challenges in multinational rare disease clinical studies during COVID-19: regulatory assessment of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease. JOURNAL OF NEUROLOGY. 2025; 272(1)DOI:10.1007/s00415-024-12843-x. PMID:39775064. IF:4.600(Q1/2D).

Salas, MQ, Solano, MT, González, MB, Gómez, MA, Fox, L, Artigas, MDP, Santamaría, A, González, MDQ, Salinas, AS, Camacho, JMS, Alvaro, VI, Abdallahi-Lefdil, Z, Navascues, JC, Pardo, L, Fernández-Luis, S, Suárez, LPV, Villar, S, Beorlegui-Murillo, P, Esquirol, A, García, II, González, SR, Mussetti, A, Lavilla, E, Lopez-Marín, J, Filaferro, S, Cedillo, A, Bento, L, Sureda, A. Frailty assessment in adults undergoing allogeneic hematopoietic cell transplantation: insights from a multicenter GETH-TC study to optimize outcomes and care. Frontiers in Immunology. 2025; 15DOI:10.3389/fimmu.2024.1512154. PMID:39840039. IF:5.900(Q1/2D).

Mayoral, V, Galvez, R, Ferrándiz, M, Vázquez, XM, Cordero-García, C, Montero, AA, Pérez, C, Pérez-Páramo, M. Pregabalin vs. gabapentin in the treatment of neuropathic pain: a comprehensive systematic review and meta-analysis of effectiveness and safety. Frontiers In Pain Research. 2025; 5DOI:10.3389/fpain.2024.1513597. PMID:39839199. IF:(Q/D).

Bougacha, S, Roquet, D, Landeau, B, Saul, E, Naveau, M, Sherif, S, Bejanin, A, Dhenain, M, Raj, A, Vivien, D, Chetelat, G, Alzheimers Dis Neuroimaging Initiative. Contributions of connectional pathways to shaping Alzheimer's disease pathologies. Brain Communications. 2025; 7(1)DOI:10.1093/braincomms/fcae459. PMID:. IF:(Q/D).

Flores-Aguilar, L, Hamlett, ED, Araya, P, Barone, E, Bhattacharyya, A, Carmona-Iragui, M, Chan, L, Christian, B, Costa, ACS, Costanzo, F, Soriano, LD, Dierssen, M, Eichler, EE, Fisher, E, Galbraith, M, Ghosh, S, Gimenez, S, Guedj, F, Guidi, S, Iulita, MF, Mobley, W, Pelleri, MC, Potier, MC, Rabin, KR, Rachubinski, A, Rebillat, AS, Rubenstein, E, Saternos, H, Sordo, L, Strydom, A, Valle-Tamayo, N, Waugh, KA, Yu, E, Zeldich, E, Busciglio, J, Head, E. Imagine, Discover, Inspire: Proceedings of the 4th International Conference of the Trisomy 21 Research Society. NEUROMOLECULAR MEDICINE. 2025; 27(1)DOI:10.1007/s12017-024-08824-y. PMID:39756004. IF:3.900(Q2/3D).

Querol, L, Dalakas, MC. The Discovery of Autoimmune Nodopathies and the Impact of IgG4 Antibodies in Autoimmune Neurology. Neurology-Neuroimmunology & Neuroinflammation. 2025; 12(1)DOI:10.1212/NXI.0000000000200365. PMID:39671536. IF:7.500(Q1/1D).

Reyes-Leiva, D, Carbayo, A, Vesperinas-Castro, A, Rojas-Garcia, R, Querol, L, Turon-Sans, J, Pla-Junca, F, Olivé, M, Gallardo, E, Pujades-Rodriguez, M, Cortés-Vicente, E. Persistent symptoms, exacerbations and drug side effects despite treatment in myasthenia gravis. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32(1)DOI:10.1111/ene.16463. PMID:39624955. IF:3.900(Q1/3D).

Cortes-Vicente, E, Guerrero-Sola, A, Caballero-Martinez, F, Campos-Lucas, FJ, Gómez-Salgado, J, Monge-Martin, D, Alvarez-Velasco, R. Practitioner's perception of myasthenia gravis management recommendations in clinical practice: a cross-sectional survey study. Therapeutic Advances in Chronic Disease. 2025; 16DOI:10.1177/20406223251368063. PMID:40949050. IF:2.800(Q2/5D).